Jesper Heldrup (Former)
1 – 10 of 30
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Simultaneous determination of folate and methotrexate metabolites in serum by LC-MS/MS during high-dose methotrexate therapy
2021) In Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 1186.(
- Contribution to journal › Article
- 2019
-
Mark
Plasma creatinine as predictor of delayed elimination of high-dose methotrexate in childhood acute lymphoblastic leukemia : A Danish population-based study
(
- Contribution to journal › Article
- 2016
-
Mark
Efficacy and Toxicity of Intrathecal Liposomal Cytarabine in First-line Therapy of Childhood Acute Lymphoblastic Leukemia
(
- Contribution to journal › Article
- 2015
-
Mark
Myelotoxicity after high-dose methotrexate in childhood acute leukemia is influenced by 6-mercaptopurine dosing but not by intermediate thiopurine methyltransferase activity
(
- Contribution to journal › Article
- 2014
-
Mark
Prognostic Implications of Mutations in NOTCH1 and FBXW7 in Childhood T-ALL Treated According to the NOPHO ALL-1992 and ALL-2000 Protocols
(
- Contribution to journal › Article
- 2013
-
Mark
Outcome of poor response paediatric AML using early SCT
(
- Contribution to journal › Article
- 2012
-
Mark
Whole-exome sequencing of pediatric acute lymphoblastic leukemia.
(
- Contribution to journal › Article
-
Mark
Gemtuzumab ozogamicin as postconsolidation therapy does not prevent relapse in children with AML: results from NOPHO-AML 2004
(
- Contribution to journal › Article
- 2010
-
Mark
Assessment Of Chemotherapy-Induced Nausea And Vomiting In Children And Adolescents With Cancer
(
- Contribution to journal › Published meeting abstract
- 2009
-
Mark
In vitro cellular drug sensitivity at diagnosis is correlated to minimal residual disease at end of induction therapy in childhood acute lymphoblastic leukemia
(
- Contribution to journal › Article